NA Stem Cell Therapy Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	151 Pages	Data Bridge Market Research	May, 2022	DAABD17330413

Best Price Guarantee
Price	from $3,500
Length	151 Pages
Publisher	Data Bridge Market Research
Published Date	May, 2022
SKU	DAABD17330413

NA Stem Cell Therapy Market - Industry Trends and Forecast to 2029

The North America stem cell therapy market is projected to register a substantial CAGR of 8.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029

Market Segmentation:
North America Stem Cell Therapy Market, Product Type (Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others), Type (Allogenic Stem Cell Therapy and Autologous Stem Cell Therapy), Application (Musculoskeletal Disorders, Acute Graft-Versus-Host Disease (AGVHD), Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others), End User (Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others), Distribution Channel (Direct Tender, Third Party Distributors), Country (U.S., Canada) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the North America stem cell therapy market are:
• The rise in the incidence of chronic diseases in the U.S.
• Growth in research and development

Market Players

Some of the major players operating in the North America stem cell therapy market are:
• Osiris Therapeutics, Inc. (A subsidiary of Smith+Nephew)
• Orthofix Medical Inc.
• Takeda Pharmaceutical Company Limited
• U.S. Stem Cell, Inc.
• BrainStorm Cell Limited
• International Stemcell Corporation
• Athersys, Inc.
• BioRestorative Therapies, Inc.
• JCR Pharmaceuticals Co., Ltd
• ANTEROGEN.CO., LTD
• MEDIPOST
• Mesoblast Ltd
• PHARMICELL Co., Ltd.
• STEMPEUTICS RESEARCH PVT LTD

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Stem Cell Therapy Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 North America Stem Cell Therapy Market: Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Product Segment Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Market End User Coverage Grid; 2.11 Secondary Sources
3 Executive Summary
4 Premium Insights: 4.1 Pestel; 4.2 Porter's Five Forces Model
5 Epidemiology
6 Pipeline Analysis For The North America Stem Cell Therapy Market
7 North America Stem Cell Therapy Market: Regulations
8 Market Overview: 8.1 Drivers; 8.1.1 The Rise In Prevalence And Incidence Of Chronic Diseases; 8.1.2 Rise In Investment In Research And Development And Availability Of Funding For Stem Cell Research; 8.1.3 Growing Biotechnology Sector; 8.1.4 Rise In Gmp Certification Approvals For Cell Therapy Production Facilities; 8.1.5 Rise In Clinical Trials For Stem-cell-based Therapies; 8.2 Restraints; 8.2.1 The Rise In Cost Of Stem-cell-based Therapy Research; 8.2.2 The Risks Faced While Undergoing Stem Cell Therapy; 8.2.3 Ethical Concerns Related To Stem Cell Therapy Research; 8.2.4 Availability Of Alternatives; 8.3 Opportunities; 8.3.1 Strategic Initiative By Market Players; 8.3.2 Rise In Healthcare Expenditure; 8.3.3 The Emergence Of Induced Pluripotent Stem Cells (Ipscs); 8.4 Challenges; 8.4.1 The Lack Of Skilled Professionals Required For Stem Cell Therapy; 8.4.2 Stringent Regulations
9 North America Stem Cell Therapy Market, By Product Type: 9.1 Overview; 9.2 Bone Marrow Derived Mesenchymal Stem Cells; 9.3 Placental/Umbilical Stem Cell; 9.4 Adipose Tissue Derived Mesenchymal Stem Cells; 9.5 Others
10 North America Stem Cell Therapy Market, By Type: 10.1 Overview; 10.2 Allogeneic Stem Cell Therapy; 10.2.1 Musculoskeletal Disorders; 10.2.2 Wounds And Injuries; 10.2.3 Acute Graft-versus-host Disease (Agvhd); 10.2.4 Surgeries; 10.2.5 Gastrointestinal Diseases; 10.2.6 Other Application; 10.3 Autologous Stem Cell Therapy; 10.3.1 Cardiovascular Diseases; 10.3.2 Gastrointestinal Diseases; 10.3.3 Other Application
11 North America Stem Cell Therapy Market, By Application: 11.1 Overview; 11.2 Musculoskeletal Disorders; 11.3 Wounds And Injuries; 11.4 Acute Graft-versus-host Disease (Agvhd); 11.5 Surgeries; 11.6 Gastrointestinal Diseases; 11.7 Cardiovascular Diseases; 11.8 Other Application
12 North America Stem Cell Therapy Market, By End User: 12.1 Overview; 12.2 Hospital And Surgical Centers; 12.3 Therapeutic Companies; 12.4 Services Companies; 12.5 Others
13 North America Stem Cell Therapy Market, By Distribution Channel: 13.1 Overview; 13.2 Direct Tender; 13.3 Third Party Distributors
14 North America Stem Cell Therapy Market, By Region: 14.1 North America; 14.1.1 U.S.; 14.1.2 Canada
15 North America Stem Cell Therapy Market: Company Landscape: 15.1 Company Share Analysis: North America
16 Swot Analysis
17 Company Profile: 17.1 Osiris Therapeutics, Inc. (A Subsidiary Of Smith+Nephew) (2021); 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Development; 17.2 Jcr Pharmaceuticals Co., Ltd ( (2021); 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Company Share Analysis; 17.2.4 Product Portfolio; 17.2.5 Recent Developments; 17.3 Orthofix Medical Inc. (2021); 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio; 17.3.5 Recent Developments; 17.4 Medipost (2021); 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Company Share Analysis; 17.4.4 Product Portfolio; 17.4.5 Recent Developments; 17.5 Takeda Pharmaceutical Company Limited (2021); 17.5.1 Company Snapshot; 17.5.2 Revenue Analysis; 17.5.3 Company Share Analysis; 17.5.4 Product Portfolio; 17.5.5 Recent Development; 17.6 Corestem, Inc. (2021); 17.6.1 Company Snapshot; 17.6.2 Revenue Analysis; 17.6.3 Product Portfolio; 17.6.4 Recent Development; 17.7 Pharmicell Co., Ltd. (2021); 17.7.1 Company Snapshot; 17.7.2 Product Portfolio; 17.7.3 Recent Developments; 17.8 Anterogen.Co., Ltd (2021); 17.8.1 Company Snapshot; 17.8.2 Product Portfolio; 17.8.3 Recent Developments; 17.9 Athersys, Inc.(2021); 17.9.1 Company Snapshot; 17.9.2 Revenue Analysis; 17.9.3 Product Portfolio; 17.9.4 Recent Developments; 17.10 Brainstorm Cell Limited (2021); 17.10.1 Company Snapshot; 17.10.2 Product Portfolio; 17.10.3 Recent Developments; 17.11 Biorestorative Therapies, Inc. (2021); 17.11.1 Company Snapshot; 17.11.2 Revenue Analysis; 17.11.3 Product Portfolio; 17.11.4 Recent Developments; 17.12 Holostem Terapie Avanzate S.R.L. (2021); 17.12.1 Company Snapshot; 17.12.2 Product Portfolio; 17.12.3 Recent Developments; 17.13 International Stemcell Corporation (2021); 17.13.1 Company Snapshot; 17.13.2 Revenue Analysis; 17.13.3 Product Portfolio; 17.13.4 Recent Development; 17.14 Mesoblast Ltd (2021); 17.14.1 Company Snapshot; 17.14.2 Revenue Analysis; 17.14.3 Product Portfolio; 17.14.4 Recent Developments; 17.15 Pluristem Inc.(2021); 17.15.1 Company Snapshot; 17.15.2 Revenue Analysis; 17.15.3 Product Portfolio; 17.15.4 Recent Development; 17.16 Stempeutics Research Pvt Ltd; 17.16.1 Company Snapshot; 17.16.2 Product Portfolio; 17.16.3 Recent Developments; 17.17 U.S. Stem Cell, Inc. (2021); 17.17.1 Company Snapshot; 17.17.2 Revenue Analysis; 17.17.3 Product Portfolio; 17.17.4 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 North America Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 2 North America Bone Marrow Derived Mesenchymal Stem Cells In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 3 North America Placental/Umbilical Stem Cell In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 4 North America Adipose Tissue Derived Mesenchymal Stem Cells In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 5 North America Others In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 6 North America Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 7 North America Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 8 North America Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 9 North America Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 10 North America Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 11 North America Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 12 North America Musculoskeletal Disorders In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 13 North America Wounds And Injuries In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 14 North America Acute Graft-versus-host Disease (Agvhd) In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 15 North America Surgeries In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 16 North America Gastrointestinal Diseases In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 17 North America Cardiovascular Diseases In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 18 North America Other Application In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 19 North America Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 20 North America Hospital And Surgical Centers In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 21 North America Therapeutic Companies In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 22 North America Services Companies In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 23 North America Others In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 24 North America Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 25 North America Direct Tender In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 26 North America Third Party Distributors In Stem Cell Therapy Market, By Region, 2020-2029 (Usd Million); Table 27 North America Stem Cell Therapy Market, By Country, 2020-2029 (Usd Million); Table 28 North America Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 29 North America Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 30 North America Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 31 North America Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 32 North America Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 33 North America Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 34 North America Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 35 U.S. Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 36 U.S. Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 37 U.S. Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 38 U.S. Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 39 U.S. Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 40 U.S. Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 41 U.S. Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million); Table 42 Canada Stem Cell Therapy Market, By Product Type, 2020-2029 (Usd Million); Table 43 Canada Stem Cell Therapy Market, By Type, 2020-2029 (Usd Million); Table 44 Canada Allogeneic Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 45 Canada Autologous Stem Cell Therapy In Stem Cell Therapy Market, By Application, 2020-2029 (Usd Million); Table 46 Canada Stem Cell Therapy Market, By Applications, 2020-2029 (Usd Million); Table 47 Canada Stem Cell Therapy Market, By End User, 2020-2029 (Usd Million); Table 48 Canada Stem Cell Therapy Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures: Figure 1 North America Stem Cell Therapy Market : Segmentation; Figure 2 North America Stem Cell Therapy Market: Data Triangulation; Figure 3 North America Stem Cell Therapy Market: Droc Analysis; Figure 4 North America Stem Cell Therapy Market: North America Vs Regional Market Analysis; Figure 5 North America Stem Cell Therapy Market: Company Research Analysis; Figure 6 North America Stem Cell Therapy Market: Interview Demographics; Figure 7 North America Stem Cell Therapy Market: Dbmr Position Grid; Figure 8 North America Stem Cell Therapy Market: Vendor Share Analysis; Figure 9 North America Stem Cell Therapy Market: End User Coverage Grid; Figure 10 North America Stem Cell Therapy Market: Segmentation; Figure 11 North America Is Anticipated To Dominate The North America Stem Cell Therapy Market And Asia-pacific Is Estimated To Be Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029; Figure 12 Increased Incidence Of Chronic Diseases, Rise In Clinical Trials, Gmp Certification And Product Appprovals Is Expected To Drive The North America Stem Cell Therapy Market From 2022 To 2029; Figure 13 Product Type Segment Is Expected To Have The Largest Share Of The North America Stem Cell Therapy Market From 2022 & 2029; Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The North America Stem Cell Therapy Market; Figure 15 Number And Ages Of People 65 Or Older With Alzheimer's Dementia In 2022; Figure 16 Incidence Of Various Types Of Cancer In 2020; Figure 17 North America Stem Cell Therapy Market: By Product Type, 2021; Figure 18 North America Stem Cell Therapy Market: By Product Type, 2022-2029 (Usd Million); Figure 19 North America Stem Cell Therapy Market: By Product Type, Cagr (2022-2029); Figure 20 North America Stem Cell Therapy Market: By Product Type, Lifeline Curve; Figure 21 North America Stem Cell Therapy Market: By Type, 2021; Figure 22 North America Stem Cell Therapy Market: By Type, 2022-2029 (Usd Million); Figure 23 North America Stem Cell Therapy Market: By Type, Cagr (2022-2029); Figure 24 North America Stem Cell Therapy Market: By Type, Lifeline Curve; Figure 25 North America Stem Cell Therapy Market: By Application, 2021; Figure 26 North America Stem Cell Therapy Market: By Application, 2022-2029 (Usd Million); Figure 27 North America Stem Cell Therapy Market: By Application, Cagr (2022-2029); Figure 28 North America Stem Cell Therapy Market: By Application, Lifeline Curve; Figure 29 North America Stem Cell Therapy Market: By End User, 2021; Figure 30 North America Stem Cell Therapy Market: By End User, 2022-2029 (Usd Million); Figure 31 North America Stem Cell Therapy Market: By End User, Cagr (2022-2029); Figure 32 North America Stem Cell Therapy Market: By End User, Lifeline Curve; Figure 33 North America Stem Cell Therapy Market: By Distribution Channel, 2021; Figure 34 North America Stem Cell Therapy Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 35 North America Stem Cell Therapy Market: By Distribution Channel, Cagr (2022-2029); Figure 36 North America Stem Cell Therapy Market: By Distribution Channel, Lifeline Curve; Figure 37 North America Stem Cell Therapy Market: Snapshot (2021); Figure 38 North America Stem Cell Therapy Market: By Country (2021); Figure 39 North America Stem Cell Therapy Market: By Country (2022 & 2029); Figure 40 North America Stem Cell Therapy Market: By Country (2021 & 2029); Figure 41 North America Stem Cell Therapy Market: By Product Type (2022-2029); Figure 42 North America Stem Cell Therapy Market: Company Share 2021 (%)